- Conditions
- Preterm Labor, Preterm Birth
- Interventions
- Multimodal intervention strategy
- Other
- Lead sponsor
- Sera Prognostics, Inc.
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 6,500 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2026
- U.S. locations
- 18
- States / cities
- San Diego, California • New Haven, Connecticut • Newark, Delaware + 15 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1705–1728
of 21,535
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
- Interventions
- Adavosertib, Paclitaxel, Carboplatin, Gemcitabine, PLD
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years to 130 Years · Female only
- Enrollment
- 95 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2023
- U.S. locations
- 18
- States / cities
- Gilbert, Arizona • Tucson, Arizona • La Jolla, California + 14 more
- Conditions
- Overweight, Obesity, Prediabetes, Meals
- Interventions
- Meal schedule
- Behavioral
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 20 Years to 60 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2019
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Prostatic Hyperplasia
- Interventions
- Dutasteride
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2005
- U.S. locations
- 11
- States / cities
- Long Beach, California • New Britain, Connecticut • Trumbull, Connecticut + 8 more
- Conditions
- Caesarean Delivery
- Interventions
- TAP Block, Ropivacaine, Acetaminophen, Morphine
- Drug
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Other
- Eligibility
- 18 Years and older · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts • Lebanon, New Hampshire
- Conditions
- Lumbar Degenerative Disc Disease
- Interventions
- SIFS graft containment device
- Device
- Lead sponsor
- Spineology, Inc
- Industry
- Eligibility
- 21 Years to 80 Years
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 10
- States / cities
- DeLand, Florida • Shreveport, Louisiana • Thibodaux, Louisiana + 7 more
- Conditions
- Acute Kidney Injury
- Interventions
- ProNephro AKI™ (NGAL)
- Diagnostic Test
- Lead sponsor
- BioPorto Diagnostics
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 4
- States / cities
- Birmingham, Alabama • New Haven, Connecticut • Boston, Massachusetts + 1 more
- Conditions
- Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
- Interventions
- doxorubicin, filgrastim, ifosfamide, biological response modifier therapy, brachytherapy, chemotherapy, colony-stimulating factor therapy, conventional surgery, cytokine therapy, intraoperative radiotherapy, radiation therapy, surgery
- Drug · Procedure
- Lead sponsor
- Radiation Therapy Oncology Group
- Network
- Eligibility
- Not listed
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 216
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 165 more
- Conditions
- Central Nervous System Metastases, Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Recurrent Childhood Central Nervous System Embryonal Tumor, Unspecified Childhood Solid Tumor, Protocol Specific
- Interventions
- sunitinib malate, pharmacological study, dynamic contrast-enhanced magnetic resonance imaging, laboratory biomarker analysis
- Drug · Other · Procedure
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Eligibility
- 2 Years to 21 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2006
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Orange, California • San Francisco, California + 11 more
- Conditions
- Emphysema, Pulmonary, Emphysema or COPD
- Interventions
- AeriSeal System
- Device
- Lead sponsor
- Pulmonx Corporation
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 20
- States / cities
- Phoenix, Arizona • Loveland, Colorado • Hartford, Connecticut + 13 more
- Conditions
- Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
- Interventions
- carboplatin, docetaxel, gemcitabine hydrochloride
- Drug
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1999 – 2010
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Pain
- Interventions
- Matrix Transdermal Fentanyl/CHADD Drug Delivery System, Placebo Patch
- Drug
- Lead sponsor
- ZARS Pharma Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006
- U.S. locations
- 15
- States / cities
- Phoenix, Arizona • Jacksonville, Florida • Marietta, Georgia + 12 more
- Conditions
- Neuroendocrine Tumors
- Interventions
- Pemetrexed
- Drug
- Lead sponsor
- Dana-Farber Cancer Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2010
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Cystic Fibrosis
- Interventions
- Gallium nitrate, Normal Saline
- Drug
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 119 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • La Jolla, California • Denver, Colorado + 20 more
- Conditions
- Burn Injury
- Interventions
- Albumin Human
- Drug
- Lead sponsor
- American Burn Association
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 101 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 24
- States / cities
- Phoenix, Arizona • Sacramento, California • Torrance, California + 21 more
- Conditions
- Alzheimer Disease
- Interventions
- Leuprolide acetate
- Drug
- Lead sponsor
- Voyager Pharmaceutical Corporation
- Industry
- Eligibility
- 65 Years and older · Male only
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2007
- U.S. locations
- 13
- States / cities
- Fresno, California • Lafayette, California • Rancho Mirage, California + 10 more
- Conditions
- Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
- Interventions
- ZD6474, Placebo, Docetaxel
- Drug
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 129 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2006
- U.S. locations
- 16
- States / cities
- Los Angeles, California • Jacksonville, Florida • Atlanta, Georgia + 13 more
- Conditions
- Early Stage Parkinson's Disease
- Interventions
- Pardoprunox
- Drug
- Lead sponsor
- Solvay Pharmaceuticals
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 202 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Oceanside, California • Oxnard, California + 10 more
- Conditions
- Epilepsy
- Interventions
- 24/7 EEG™ SubQ system
- Device
- Lead sponsor
- UNEEG Medical A/S
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Tampa, Florida • Boston, Massachusetts + 6 more
- Conditions
- Small-Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Carcinoma of the Lung
- Interventions
- 225Ac-ABD147
- Drug
- Lead sponsor
- Abdera Therapeutics Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 12
- States / cities
- Newport Beach, California • San Francisco, California • Santa Monica, California + 9 more
- Conditions
- Posttraumatic Stress Disorder
- Interventions
- losartan, Placebo
- Drug
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 149 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2020
- U.S. locations
- 6
- States / cities
- La Jolla, California • Washington D.C., District of Columbia • Bethesda, Maryland + 3 more
- Conditions
- Aging, Age-related Cognitive Decline, Obesity
- Interventions
- Strawberry, Placebo
- Dietary Supplement · Other
- Lead sponsor
- USDA Human Nutrition Research Center on Aging
- Federal
- Eligibility
- 55 Years to 75 Years
- Enrollment
- 47 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2023
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Breast Cancer, Metastatic Cancer
- Interventions
- dasatinib
- Drug
- Lead sponsor
- SWOG Cancer Research Network
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2014
- U.S. locations
- 117
- States / cities
- Mobile, Alabama • Anchorage, Alaska • Bentonville, Arkansas + 76 more
- Conditions
- Essential Tremor
- Interventions
- Transcranial ExAblate
- Device
- Lead sponsor
- InSightec
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2023
- U.S. locations
- 7
- States / cities
- Stanford, California • Baltimore, Maryland • Boston, Massachusetts + 4 more